Arroyo Research selects Nextphase ctSeries platform for clinical trial data management

"We are delighted to partner with Arroyo Research in establishing an electronic network among its growing number of affiliated sites across the country,” said Michael Currie, CEO of Nextphase.



"We are delighted to partner with Arroyo Research in establishing an electronic network among its growing number of affiliated sites across the country, said Michael Currie, CEO of Nextphase. By doing so, we can support ARI's mission of providing world class clinical research to the pharmaceutical, biotechnology, and medical device industries.

"ARI is one of the first clinical research organizations to leverage Nextphase's Web-based ctSeries," Currie said. "Which delivers application hosting and comprehensive professional services that significantly reduce cycle times and help speed clinical development."

"With the Nextphase ctSeries as our clinical research technology platform we will be able to maintain mission-critical communications with our many research sites, ensuring the rapid acquisition of high-quality data throughout the clinical trial process," said Henry Sideropoulos, M.D. and CEO of Arroyo Research. "And because the ctSeries is fully scalable, it will enable us to handle the growing needs of our clients in the years ahead."